Author: Cavalli, Giulio; Dagna, Lorenzo
Title: Anakinra for COVIDâ€19: how to interpret elevations in serum liver enzymes Cord-id: t5owxikr Document date: 2020_9_22
ID: t5owxikr
Snippet: We read with interest the study by Navarroâ€Millà n and colleagues on the use of anakinra in severe COVIDâ€19 patients with acute respiratory insufficiency and hyperâ€inflammation (1). The Authors tried to identify the clinical phenotype that is most likely to benefit from anakinra treatment, in order to maximize utility and not to expose patients to unnecessary risks related to immunosuppression.
Document: We read with interest the study by Navarroâ€Millà n and colleagues on the use of anakinra in severe COVIDâ€19 patients with acute respiratory insufficiency and hyperâ€inflammation (1). The Authors tried to identify the clinical phenotype that is most likely to benefit from anakinra treatment, in order to maximize utility and not to expose patients to unnecessary risks related to immunosuppression.
Search related documents:
Co phrase search for related documents- liver enzyme and macrophage activation syndrome: 1, 2
Co phrase search for related documents, hyperlinks ordered by date